Posttraumatic stress disorder in adolescents Mental and Behavioural Disorders
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Adolescents from 12 to 18 years old seen at the mental health outpatient policlinics of the Opvoedpoli or Care-Express in Amsterdam. They are referred by their general practitioner, the Ouder- en Kindteam or Jeugdteam, or medical specialist. 2. 30 points or more on the Dutch version of the Children's Revised Impact of Events Scale (CRIES-13; Verlinden et al., 2005) 3. A PTSD diagnosis as measured by the Dutch version of the CAPS-CA (Van Meijel et al., 2019) 4. At least four traumatic experiences that give rise to reliving and fear, type II trauma (Terr, 1991) 5. Sufficient knowledge of the Dutch language to undergo treatment 6. Involvement of at least one support figure from the network 7. Abstinence from soft drugs and alcohol during the 2-week period of the intensive trauma treatment
Exclusion criteria
Exclusion criteria: 1. Severe intellectual disability defined as an estimated IQ of 70 or less 2. Not being able or unwilling to recall the traumatic memories 3. Not being able or unwilling to follow intensive trauma treatment 4. Unsafe home situation, for example with ongoing abuse at home 5. Suicidality is only an exclusion criterion if there are concrete plans or if this requires medical care
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Trauma complaints measured with the CRIES-13 daily during the baseline and 2-week intervention period | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Tolerability of the intensive trauma therapy measured with the Session Rating Scale (SRS) on each treatment day during the intervention period (eight times) 2. Tolerability of the intensive trauma treatment measured using a self-developed semi-structured interview at posttest 3. PTSD diagnosis measured with the Clinician Administered PTSD Scale for Children and Adolescents (CAPS-CA) at pretest and at 1 and 3-months follow-up 4. Trauma complaints measured with the CRIES-13 at pretest, posttest, 1-month and 3-months follow-up | — |
Countries
Netherlands